Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Aims: Our aim was to evaluate the longitudinal associations of individual and multiple vascular risk factors with the subsequent development of dementia and Alzheimer’s disease (AD). Methods: The Uppsala Longitudinal Study of Adult Men started in 1970 when the 2,268 participants were 50 years old. Baseline investigations included determinations of blood pressure, fasting glucose, cholesterol, BMI and smoking status. Over a maximum follow-up of 40 years, 349 participants were diagnosed with dementia, out of which 127 had AD. Analyses were repeated using a re-examination of the cohort at 70 years of age as a baseline. Results: No associations between vascular risk factors and AD were found. For all-type dementia, the association between high systolic blood pressure and dementia was the most consistent. High fasting glucose was associated with increased risk of all-type dementia only when measured at 70 years. Individuals with both an APOE Ε4 allele and vascular risk factors had the greatest dementia risk. Conclusion: Vascular risk factors influence the future risk of dementia, in particular vascular and mixed-type rather than AD. The impact of vascular risk factors on dementia in a longitudinal study depends on the age at baseline and the length of follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, midlife obesity, 105,111,112 hypertension, 85,[105][106][107] prehypertension (systolic blood pressure from 120 to 139 mm Hg or diastolic pressure from 80 to 89 mm Hg) 85 and high cholesterol 113 are associated with an increased risk of dementia in later life.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [105]
In the citing paper
“These factors include hypertension 85,[105][106][107] and diabetes.[108][109][110]”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [105]
In the citing paper
“Many factors that increase the risk of cardiovascular disease are also associated with a higher risk of dementia. 114 These factors include hypertension, 91 , 115 , 116 , 117 diabetes 118 , 119 , 120 and smoking. 121 , 122”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [115]
In the citing paper
“For example, midlife obesity, 115 , 147 , 148 hypertension, 91 , 115 , 116 , 117 and high cholesterol 149 are among the midlife factors associated with an increased risk of dementia in later life.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [115]
In the citing paper
“while 2 found this relationship for some outcomes but not others [97,103]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [103]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Lerner, D. J., & Kannel, W. B. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90155-9 · Cited by 1,725 · cited 1×
“However, individuals with both APOE e4 and vascular risk factors certainly have the highest risk of developing dementia, irrespective of the cause.Our results are derived from a large community-based population over a long follow-up period. However, as we only examined men of the same age with a similar ethnic backgro…”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
McKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1803 · Cited by 1,472 · cited 1×
“frontotemporal dementia according to the McKhann criteria [”
MethodMidlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · cited 1×
“Midlife vascular risk factors and late-life dementia have been studied in a number of longitudinal cohorts, but the results are far from conclusive [”
BackgroundChui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992) · Neurology · doi:10.1212/wnl.42.3.473 · Cited by 1,201
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · cited 1×
“Amyloid accumulation eventually leading to AD neurodegeneration starts decades before clinical symptoms emerge [”
Background
Cited by
Items 101–171 of 171
Rotonen, S., AUVINEN, J. P., Bloigu, A. H., Härkönen, P. K., Jokelainen, J. J., Timonen, M., & Keinanen-Kiukaanniemi, S. M. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109045 · Cited by 11
No, H.-J., Yi, H., Won, K. S., Chang, H. W., & Kim, H. W. (2019) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2019.01.005 · Cited by 13
Rogne, S., Vangberg, T. R., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000350408 · Cited by 11
Lau, W. K., Mak, J., Chan, K. H., & Law, A. C.-K. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9301-8 · Cited by 12
Vaskuläre Demenz und Hypertonie
Lüders, S., & Schrader, J. (2015) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-105598 · Cited by 10
Huang, C., Weng, S., Wang, J., & Hsieh, H. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1720598 · Cited by 9
Multisystem failure, tipping points, and risk of Alzheimer's disease
Merlini, S., Bedrick, E. J., Brinton, R. D., & Vitali, F. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70249 · Cited by 11
Ma, J., Cao, X., Chen, F., Ye, Q., Qin, R., Cheng, Y., Zhu, X., & Xu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.614220 · Cited by 10
Metabolic parameters and cognitive function in a cohort of older diabetic patients
Herghelegiu, A. M., Nacu, R. M., & Prada, G. I. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0515-0 · Cited by 10
“Epidemiological research on association between plasma cholesterol, and its sub-fractions levels, and risk of dementia has generated inconsistent and conflicting findings [29–33].”
The Janus-like Association between Proton Pump Inhibitors and Dementia
Papazoglou, A., Arshaad, M. I., Henseler, C., Daubner, J., Broich, K., Haenisch, B., & Weiergräber, M. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210929144740 · Cited by 8
Зуева, И. Б. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh2015871296-100 · Cited by 8
Buawangpong, N., Aramrat, C., Pinyopornpanish, K., Phrommintikul, A., Soontornpun, A., Jiraporncharoen, W., Pliannuom, S., & Angkurawaranon, C. (2022) · Healthcare · doi:10.3390/healthcare10101959 · Cited by 8
Wei, J., Xu, H., Zhang, D. “., Tang, H., Wang, T., Steck, S. E., Divers, J., Zhang, J., & Merchant, A. T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230398 · Cited by 7
“Evidence from prospective cohort studies has indicated that high blood pressure in midlife is associated with a higher risk of cognitive decline and dementia [2–5].”
Relationship Between Blood Pressure and Physical and Cognitive Function in the Oldest Old
Kuyumcu, M. E., Yeşil, Y., Doğu, B. B., Halil, M. G., Cankurtaran, M., & Arıoğul, S. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12232 · Cited by 6
Cell‐to‐Cell Communication and Vascular Dementia
Dietrich, H. H. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2012.00175.x · Cited by 6
Silva, A. M. P., Gonçalves, O. R., Tudella, G. C. N., Nascimento, M. V. S., Pereira, M. A. O. M., Nantes, L. A. D. O., Fernandes, J. V. A., Quiroga, D. G., Lima, D. V. S., Jr., Franco, E. S., et al. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.11.005 · Cited by 7
COGNITION DISORDERS IN HYPERTENSIVE PATIENTS OF OLDER AGE AND SENILE
Шарашкина, Н. В., Сергеевна, О. В., Tkacheva, О. N., Рунихина, Н. К., Kotovskaya, Y. V., Mkhitaryan, E. A., & Lysenkov, S. N. (2017) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2017-3-34-38 · Cited by 5
Blood pressure screening in midlife aids in prediction of dementia later in life
Moberg, L., Leppert, J., Liljeström, S., Rehn, M., Kilander, L., & Chabok, A. (2022) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v127.7860 · Cited by 5
“On the other hand, some previous cohort studies with repeated blood pressures presented results in line with ours regarding AD (15, 25).”
ResultSelf-citationLi, X.-L., Wang, R.-T., Tan, C., Tan, L., & Xu, W. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1448034 · Cited by 6
Liu, C., Pan, F., Sun, Z., Chen, Z., & Wang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-52094-4 · Cited by 5
No, H.-J., Yi, H.-A., Won, K. S., Chang, H. W., & Kim, H. W. (2019) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2018.12.001 · Cited by 10
VASCULAR DISEASE BURDEN AND DEMENTIA
Chandra, M., & Anand, K. S. (2015) · Australasian Medical Journal · doi:10.4066/amj.2015.2390 · Cited by 4
Wijesinghe, P., Wijeweera, G., & de Silva, K. R. D. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-22468-3_7 · Cited by 4
Shin, H.-M., Ha, W., Kim, J., Park, S. H., Han, K., & Baek, M. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300379 · Cited by 3
Connections Between Hypertension, Atherosclerosis, Acute Myocardial Infarction, and Risk of Dementia
Stern, A., & Frishman, W. H. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000739 · Cited by 4
Features of cognitive disorders in elderly and old patients with hypertension
Шарашкина, Н. В., Сергеевна, О. В., & Рунихина, Н. К. (2018) · Russian Family Doctor · doi:10.17816/rfd2018136-40 · Cited by 3
“В клинических проспективных исследованиях было продемонстрировано, что когнитивные расстрой ства у людей старшей возрастной группы, по край ней мере частично, связаны с АГ [12, 13].”
Hipertensión arterial y demencia: una relación compleja
Camafort, M., & Sierra, C. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.09.018 · Cited by 5
Epidemiology and risk factors for dementia
Yaffe, K. S., & Hazzouri, A. Z. A. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.005 · Cited by 3
Luo, W., Wen, H., Ge, S., Tang, C., Liu, X., & Lu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.774804 · Cited by 4
“Risk factors were selected as described in previous reports (Stewart et al., 2009; Debette et al., 2011; Rönnemaa et al., 2011; Yang et al., 2011; Joas et al., 2012; Loy et al., 2014; Ben Bouallègue et al., 2017; Donohue et al., 2017; Gottesman et al., 2017; Abell et al., 2018; Alzheimer’s disease facts and figures, 2…”
MethodEakins, D. R., Williams-Nguyen, J. S., Schoenberg, N. E., & Tofaeono, V. (2025) · SSM - Mental Health · doi:10.1016/j.ssmmh.2025.100446 · Cited by 2
“hypertension, and type 2 diabetes (Anstey et al., 2011; Gudala et al., 2013; Launer et al., 2000; Loef and Walach, 2013; Rönnemaa et al., 2011).”
Hellquist, E., Janelidze, S., Weidung, B., Franzon, K., Giedraitis, V., Ingelsson, M., Bali, D., Veličkaitė, V., Zetterberg, H., Hansson, O., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251390387 · Cited by 2
“38 Follow-up diagnostics were made using all data available in medical records from Uppsala University Hospital, primary care, and nursing homes in Uppsala County until December 31, 2022, i.e., up to age of 102 in survivors.”
Self-citationMoon, H. E., Lee, Y.-S., Roh, S., Allick, C. C., Galvin, J. E., & Stone, S. T. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf131 · Cited by 2
Bueno‐Notivol, J., Gracia‐García, P., Olaya, B., de la Cámara, C., López‐Antón, R., & Santabárbara, J. (2022) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2022.09.006 · Cited by 2
Xu, Q., Zou, K., Deng, Z., Zhou, J., Dang, X., Zhu, S., Liu, L., & Fang, C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220316 · Cited by 2
“…suchasgenetics[9]andfamilyhistory[10];lifestyle factors,suchasalackofsocialandmentalactivity [11],lackofphysicalexercise,smoking,anddrinking alcohol [12]; and physical diseases, such as hypertension, diabetes [12], traumatic brain injury [13], and cardiovascular disease risk factors [14].”
Huang, C.-Y., Wu, M., Huang, M., Yu, T., & Yen, H. (2023) · Integrative Medicine Research · doi:10.1016/j.imr.2023.100981 · Cited by 4
Arafa, A., Kawachi, H., Kato, Y., Nosaka, S., Teramoto, M., Khairan, P., Gao, Q., Matsumoto, C., & Kokubo, Y. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123244 · Cited by 2
Risk of dementia in patients with age‐related medical conditions: a retrospective cohort study
Kim, H. (2024) · Psychogeriatrics · doi:10.1111/psyg.13222 · Cited by 2
Floud, S., Hermon, C., Whiteley, W. N., Fitzpatrick, K. E., & REEVES, G. K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70595 · Cited by 1
Son, J., Lee, W., & Kim, Y. (2025) · Obesity Reviews · doi:10.1111/obr.70078 · Cited by 3
Lee, Y.-S., Roh, S., Moon, H. E., Steele, J. S., Yoon, D. P., & Warne, D. K. (2026) · Journal of Applied Gerontology · doi:10.1177/07334648261459708 · Cited by 1
Cong, Y.-L., Wang, Y.-C., Huang, L.-Y., Yang, Z.-L., Tan, L., Chu, X.-H., & Xu, W. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100800 · Cited by 1
Specific Effects of Anti-Hypertensive Treatment in an Older Patient with Dementia
Zmudka, J., Sérot, J., Dao, S., Sorel, C., Macaret, A.-S., & Balédent, O. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010015 · Cited by 1
“The presence of vascular risk factors such as hypertension (HT) may increase the risk of AD [1,2].”
Dementia: Risk Factors and Updated Review
Nepal, H., Jeffrey, B., & Bhattarai, M. (2018) · Journal of Psychiatrists Association of Nepal · doi:10.3126/jpan.v6i2.21750 · Cited by 2
Hypertonie und die Folgen für kognitive Funktionsstörungen und Demenz
Schrader, J., & Lüders, S. (2016) · CardioVasc · doi:10.1007/s15027-016-0744-y · Cited by 3
“Bezug genommen wird hierbei auf eine kürzlich erschienene ausführliche Darstellung des emas [4, 5].”
BackgroundVaskularni kognitivni upad in vaskularna demenca
Ovčar, K., Potočnik, J., & Rakuša, M. (2017) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1543 · Cited by 3
Luo, W., Hao, W., Ge, S., Tang, C., Liu, X., & Lu, L. (2021) · Research Square · doi:10.21203/rs.3.rs-517520/v1 · Cited by 1
BIRTH COHORT EFFECTS IN RISK FACTORS FOR ALZHEIMER'S DISEASE
Uzodinma, K. (2016) · UKnowledge (University of Kentucky)
Ali, A. A., & Ali, A. A. (2017) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000241
ДОБОВИЙ ПРОФІЛЬ АРТЕРІАЛЬНОГО ТИСКУ ТА КОГНІТИВНІ ПОРУШЕННЯ
Skybchyk, V. А., & Peleshko, O. S. (2019) · Здобутки клінічної і експериментальної медицини · doi:10.11603/1811-2471.2019.v0.i1.10063
Risk factors for development of neurocognitive disorders
Gustavsson, A. (2019) · Lund University Publications (Lund University)
Cardiovascular causes of dementia
Demir, F. A. (2019) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.633782
The role of blood pressure and hypertension in dementia
Walker, K. A., & Gottesman, R. F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00008-2 · Cited by 2
Rusanen, M. (2013) · UEF eRepo (University of Eastern Finland) · Cited by 3
Li, X., wu, Q., Chen, X., Tang, Y., Fei, B., Zhao, Q., Ding, J., & Wang, X. (2023) · medRxiv · doi:10.1101/2023.10.20.23297342
Wang, H., Che, Y., Gao, J., Huang, Y., Zeng, L., Liao, X., Zeng, Z., Wen, L., Liu, Y., & Mo, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-3936524/v1
DEMÊNCIA VASCULAR: EXPLORANDO OS MECANISMOS, DIAGNÓSTICO E INTERVENÇÕES - UMA REVISÃO BIBLIOGRÁFICA
Cardoso, A. M. S., Aguiar, M. J. N. O., de Medeiros, S. G. L., de Medeiros, G. L., Silva, M. C. D. A., Souza, P. L. B., de Oliveira, N. S. C., & de Oliveira, C. S. (2024) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v5i3.4981
Liu, X., Hu, Y., & Jin, H. (2024) · Research Square · doi:10.21203/rs.3.rs-5311665/v1
Cardiovascular Risk Factors From Early Childhood and Cognitive Function in Young Adulthood
Salo, H., Pahkala, K., Niinikoski, H., Lagström, H., Salo, P., Jula, A., Ronnemaa, T., Viikari, J., Raitakari, O. T., & Rovio, S. (2026) · PEDIATRICS · doi:10.1542/peds.2025-071353 · Cited by 3
A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease
Murray, S., Akiyoshi, K., Isaacson, R., Dayspring, T. D., & Niotis, K. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.009
Xue, L., Bocharova, M., Young, A. H., & Aarsland, D. (2026) · BJPsych Open · doi:10.1192/bjo.2026.10995 · Cited by 1
“32 Apart from this, depression can be prodromal to neurodegenerative diseases.”
An Integrated Approach on Vascular Cognitive Impairment
Jianu, D. C., Jianu, S. N., Bora, B. I., Munteanu, G., Bertici, R.-A., Dan, T. F., & Petrică, L. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014841
Human APOB-expressing mice translate molecular phenotypes across the Alzheimer’s disease spectrum
Aumont‐Rodrigue, G., Poirier, A., Picard, C., & Poirier, J. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106575
Toublet, F. (2019) · theses.fr (ABES) · doi:10.70675/ce2e69d8zf6fez40cdz9605z8b0883cefb6a · Cited by 2
Développement de formes vectorisables innovantes dans le cadre de maladies liées à l'âge
Iskandar, S. (2019) · theses.fr (ABES) · doi:10.70675/1d771122z75d0z4ba8z8ee6zbd1a858ffc38
Comorbidity sequence, sex, and APOE-genotype forecast Alzheimer's disease diagnosis
Merlini, S., Gatta, R., Orini, S., Basharat, A., Farooq, M., Brinton, R. D., & Vitali, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1826377
Xu, L., Tong, Q., & Ye, H. (2026) · Research Square · doi:10.21203/rs.3.rs-10279428/v1
Schneider, N., Frank, T., Müller, A., & Meier, C. (2026) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/uhj49jdnzc
Tyjas, K. K., Rusinek, J., Ziółek, W. Z., Rajzer, M., Gruszka, A., & Stolarz‐Skrzypek, K. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107261
Metadata
- Authors
- Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Dementia and Geriatric Cognitive Disorders
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 31
- Issue
- 6
- Pages
- 460-466
- ISSN
- 1420-8008 (ISSN-L)
- 1421-9824
- OpenAlex
- W2019386454
- Cited by
- 171
- References
- 31
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 12 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 18 · 2016: 13 · 2015: 12 · 2014: 9 · 2013: 9 · 2012: 4
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- vascular risk factors, dementia, Alzheimer's disease, systolic blood pressure, fasting blood glucose, APOE ε4, vascular dementia, age at baseline, cohort follow-up
- MeSH terms
- Aged, Apolipoproteins E, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Data Interpretation, Statistical, Dementia, Humans, Male, Middle Aged, Population, Risk Factors, Smoking, Sweden, Cohort Studies, Body Mass Index, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.